Healy D, Carney P A, O'Halloran A, Leonard B E
J Affect Disord. 1985 Nov;9(3):285-96. doi: 10.1016/0165-0327(85)90059-x.
Changes in platelet and lymphocyte adrenoceptor densities, platelet serotonin uptake and aggregatory response to serotonin were assessed in a group of moderately depressed patients before and during treatment with either trazodone or amitriptyline. Platelet serotonin receptor activity and uptake were lower before the start of treatment in all patients than in those patients responding to treatment. The densities of alpha 2- and beta-adrenoceptors tended to be higher in the patients before treatment and returned to control values after effective therapy. There were no major differences in the biochemical changes between the patients treated with trazodone or amitriptyline. When the biochemical data was correlated with the clinical history of the patients, it was found that only endogenously depressed patients, and not those with non-endogenous depression, had a significantly reduced platelet serotonin uptake rate. In addition, female depressives had a slightly lower platelet 5-HT aggregatory response than males irrespective to the type of depression.
在一组中度抑郁症患者中,评估了使用曲唑酮或阿米替林治疗前及治疗期间血小板和淋巴细胞肾上腺素能受体密度、血小板5-羟色胺摄取以及对5-羟色胺的聚集反应。所有患者在治疗开始前血小板5-羟色胺受体活性和摄取均低于对治疗有反应的患者。治疗前患者的α2和β肾上腺素能受体密度往往较高,有效治疗后恢复至对照值。使用曲唑酮或阿米替林治疗的患者之间生化变化无重大差异。当生化数据与患者临床病史相关联时,发现只有内源性抑郁症患者而非非内源性抑郁症患者血小板5-羟色胺摄取率显著降低。此外,无论抑郁症类型如何,女性抑郁症患者的血小板5-羟色胺聚集反应略低于男性。